This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/kegg-compound/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/bindingdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/drugbank/
n17http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01796/identifier/chebi/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01796
rdf:type
n3:Drug
n3:description
A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. [PubChem]
n3:group
experimental
owl:sameAs
n15:DB01796 n17:DB01796
dcterms:title
Quinolinic Acid
adms:identifier
n6:46505240 n7:NTM n8:1066 n9:26115 n10:DB01796 n11:C03722 n12:16675 n13:1037
n3:synthesisReference
Robert W. J. Rebhahn, James E. Kassner, Raymond E. Werner, "Process for preparing quinolinic acid." U.S. Patent US4537971, issued March, 1945.
n3:IUPAC-Name
n4:271B476B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4771-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4770-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B476D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B476E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B476F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4769-363D-11E5-9242-09173F13E4C5 n4:271B4781-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B476A-363D-11E5-9242-09173F13E4C5 n4:271B4767-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4768-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B4783-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4777-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4778-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4772-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4773-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4775-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4774-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4776-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
89-00-9
n3:Bioavailability
n4:271B477D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B477F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4780-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4782-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B477C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B477B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B477E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B476C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4779-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B477A-363D-11E5-9242-09173F13E4C5